We continue with the next video in the series of Tu Farmacéutico Informa video advice focused on raising awareness of biosimilar biological medicines in the diseases in which these drugs are most used.
We continue with the next video in the series of Tu Farmacéutico Informa video advice focused on raising awareness of biosimilar biological medicines in the diseases in which these drugs are most used.
Let's first remember what a biosimilar is. When a biological medicine loses its patent and its exclusivity in the market, it opens up to competition, making it possible for other laboratories to market the same medicine.
And these are biosimilar drugs: biological medications that are prescribed by your doctor and that have the same quality, safety and effectiveness as the original biological.
Deep vein thrombosis is a serious disease that occurs when a blood clot, also called a thrombus, forms in the deep veins of your body. Normally, the most common symptoms are swelling and pain in the legs, which is the most common area in which these thrombi appear. One of the complications with the greatest impact on patients' health arises if this clot dislodges from the vein.
This would travel through the bloodstream until it reaches the lungs, potentially blocking blood flow and causing a pulmonary embolism. This is why the general prevention of venous thrombosis is so important and in case of risk, enoxaparin sodium is an anticoagulant medication that helps avoid complications and problems that irreversibly affect health.
It is estimated that in 2022 alone in Spain more than 20.000 patients will have been diagnosed with deep vein thrombosis, so having drugs to prevent it in time is essential.
The arrival of biological medications has been an unprecedented milestone in the prevention of thrombosis. Therefore, the appearance of biosimilar medications is good news since it makes these treatments more accessible with the same health results.
The biosimilar currently used for deep vein thrombosis is enoxaparin sodium. This is a low molecular weight heparin that is responsible for inhibiting coagulation. It is administered subcutaneously, so you can administer it yourself at home. There are two types of devices, syringes and prefilled pens. Remember that each device has specific application instructions, so it is important that either your healthcare professional teaches you how to administer it yourself or someone around you.
For optimal storage, these injectable medications should not be frozen and should generally be stored at temperatures below 25ºC.
Remember, always ask your trusted pharmacist, the healthcare professional who is expert in the medication. We will inform you and resolve any questions you may have.
We continue with the next video in the series of Tu Farmacéutico Informa video advice focused on raising awareness of biosimilar biological medicines in the diseases in which these drugs are most used.
Let's first remember what a biosimilar is. When a biological medicine loses its patent and its exclusivity in the market, it opens up to competition, making it possible for other laboratories to market the same medicine.
And these are biosimilar drugs: biological medications that are prescribed by your doctor and that have the same quality, safety and effectiveness as the original biological.
Deep vein thrombosis is a serious disease that occurs when a blood clot, also called a thrombus, forms in the deep veins of your body. Normally, the most common symptoms are swelling and pain in the legs, which is the most common area in which these thrombi appear. One of the complications with the greatest impact on patients' health arises if this clot dislodges from the vein.
This would travel through the bloodstream until it reaches the lungs, potentially blocking blood flow and causing a pulmonary embolism. This is why the general prevention of venous thrombosis is so important and in case of risk, enoxaparin sodium is an anticoagulant medication that helps avoid complications and problems that irreversibly affect health.
It is estimated that in 2022 alone in Spain more than 20.000 patients will have been diagnosed with deep vein thrombosis, so having drugs to prevent it in time is essential.
The arrival of biological medications has been an unprecedented milestone in the prevention of thrombosis. Therefore, the appearance of biosimilar medications is good news since it makes these treatments more accessible with the same health results.
The biosimilar currently used for deep vein thrombosis is enoxaparin sodium. This is a low molecular weight heparin that is responsible for inhibiting coagulation. It is administered subcutaneously, so you can administer it yourself at home. There are two types of devices, syringes and prefilled pens. Remember that each device has specific application instructions, so it is important that either your healthcare professional teaches you how to administer it yourself or someone around you.
For optimal storage, these injectable medications should not be frozen and should generally be stored at temperatures below 25ºC.
Remember, always ask your trusted pharmacist, the healthcare professional who is expert in the medication. We will inform you and resolve any questions you may have.